Omar Njie, MD, MPH, is a Principal at AlleyCorp, where he invests in and builds early-stage companies transforming healthcare through technology. His work spans clinical AI, healthcare infrastructure, care delivery, and the life sciences. He incubated Glidepath Health, and his investments and board experience include OMNY Health, PraxisPro, Rhino Federated Computing, and Transcend Therapeutics, which was acquired by Otsuka in 2026. Before joining AlleyCorp, Omar worked at Clover Health and Deloitte. He holds an MD from the Icahn School of Medicine at Mount Sinai and an MPH and BA from Yale.